Heart:强化动机式访谈干预对心血管高风险人群无明显效果

2020-03-12 MedSci原创 MedSci原创

肥胖的流行正导致心血管疾病高危人群的患病率不断上升,进而否定了降低心血管疾病死亡率的医学进展。本研究目的旨在评估评估减轻心血管病高危患者的体重和增加体力活动强化生活方式干预的临床效果和成本效益。

肥胖的流行正导致心血管疾病高危人群的患病率不断上升,进而否定了降低心血管疾病死亡率的医学进展。本研究目的旨在评估评估减轻心血管病高危患者的体重和增加体力活动强化生活方式干预的临床效果和成本效益。

本研究纳入了伦敦40-74岁未来十年可能发生心血管疾病事件的患者,干预措施为强化动机式访谈,包括额外的行为改变技巧,由健康培训师在1年内分10次以小组(n=697)或个人(n=523)的形式进行。第三组患者接受了常规的护理(UC组,n=522),主要终点事件是活动量(平均步数/日)和体重(Kg),次要终点事件是低密度脂蛋白胆固醇和心血管风险评分的变化。经过24个月的随访,干预组患者在增加活动量和降低体重方面与对照组均无明显变化,对次要终点事件的发生也无明显差异。

研究结果显示,在心血管疾病高风险人群中,用额外的行为改变技巧加强动机式访谈对减轻体重或增加体力活动无明显效果。

 

原始出处:

Khalida I et al.Reducing weight and increasing physical activity in people at high risk of cardiovascular disease: a randomised controlled trial comparing the effectiveness of enhanced motivational interviewing intervention with usual care.Heart.2020 Mar.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1862120, encodeId=d80a1862120fe, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Mon Mar 23 14:26:38 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357432, encodeId=218a135e43216, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Mar 14 13:26:38 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563254, encodeId=c69a1563254aa, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Mar 14 13:26:38 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047011, encodeId=3d6d104e011aa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 13 01:26:38 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1862120, encodeId=d80a1862120fe, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Mon Mar 23 14:26:38 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357432, encodeId=218a135e43216, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Mar 14 13:26:38 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563254, encodeId=c69a1563254aa, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Mar 14 13:26:38 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047011, encodeId=3d6d104e011aa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 13 01:26:38 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2020-03-14 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1862120, encodeId=d80a1862120fe, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Mon Mar 23 14:26:38 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357432, encodeId=218a135e43216, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Mar 14 13:26:38 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563254, encodeId=c69a1563254aa, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Mar 14 13:26:38 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047011, encodeId=3d6d104e011aa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 13 01:26:38 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2020-03-14 slcumt
  4. [GetPortalCommentsPageByObjectIdResponse(id=1862120, encodeId=d80a1862120fe, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Mon Mar 23 14:26:38 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357432, encodeId=218a135e43216, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Mar 14 13:26:38 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563254, encodeId=c69a1563254aa, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Mar 14 13:26:38 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047011, encodeId=3d6d104e011aa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 13 01:26:38 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2020-03-13 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

相关资讯

JACC:年轻心梗患者远期死亡率的研究

2型心梗和心肌损伤会增加患者短期死亡风险,然而对长期风险的影响尚不清楚。本研究的目的旨在评估年轻1型心梗、2型心梗或心肌损伤患者的远期死亡风险。本研究纳入分析了3829名年龄≤50岁的患者(平均年龄44岁,女性占30%),其中55%为1型心梗,32%为2型心梗,13%为心肌损伤。经过平均10.2年时间的随访,心肌损伤患者的死亡率最高,其次是2型心梗。与1型心梗相比,2型心梗与更高的全因和心血管死亡

JACC:心肌炎患者的室性心律失常研究

心肌炎患者不同时期的室性心律失常(VAs)尚未得到系统的研究。本研究的目的是比较活动性心肌炎(AM)与既往心肌炎(PM)患者VAs的基线和随访临床特征。

JACC:即时高敏肌钙蛋白检测试剂盒对疑似心梗具有较好的诊断价值

目前,高敏肌钙蛋白(hs-cTn)试剂盒检测多用于医院大型实验平台。本研究旨在评估即时hs-cTn检测试剂盒(POC-hs-cTn)对心梗疑似患者的诊断价值。

盘点:JACC3月第二期研究一览

1. 睡眠不规律是心血管疾病的独立危险因素

JACC:三尖瓣手术可降低成年先心病术后患者反流程度

三尖瓣返流(TR)在成人因法洛四联症(TOF)或肺动脉狭窄(PS)而需要肺动脉瓣置换术(PVR)的患者中很常见,本研究的目的旨在评估三尖瓣手术对先心病术后患者预后的影响。

JACC:紫杉醇涂层球囊可降低冠心病患者远期死亡率

药物涂层球囊(DCBs)是冠状动脉支架内再狭窄公认的治疗策略,目前正在对未经支架植入的病变进行临床研究。最近发表的一项荟萃分析显示,在股浅动脉内使用紫杉醇涂层装置会增加死亡风险。本分析的目的是从随机对照试验(RCT)中评估紫杉醇涂层球囊冠状动脉介入治疗后的存活率。本研究纳入分析了来自26个RCTs的4590名患者,在随访6-12个月期间,DCB组和非DCB组患者的全因死亡率无明显差异,随访2年的死